Stryker Corp. Stock Falls 0.27% Wednesday Amid Mixed Market Performance

July 27, 2023

🌥️Trending News

Wednesday was a difficult day for Stryker Corporation ($NYSE:SYK)’s stock, as it closed at $290.12, which represented a 0.27% decline from the previous day. This was despite a mixed performance from the Dow Jones Industrial Average, which had an overall positive day. Stryker Corporation is a medical technology company based in Kalamazoo, Michigan.

It specializes in the development, manufacturing, and distribution of medical equipment, such as surgical equipment, surgical navigation systems, endoscopes, and hospital beds. Wednesday’s decline was a setback for the company, but investors will be hoping that it can resume its strong performance in the near future.

Analysis

At GoodWhale, we analyzed the financials of STRYKER CORPORATION and determined that they fall under the “rhino” classification, indicating that they have achieved moderate revenue or earnings growth. This makes them an attractive investment option for those investors looking for steady, reliable growth. We also evaluated STRYKER CORPORATION’s health score, which currently stands at 8/10. This is based on their cashflows and debt and indicates that they are capable of sustaining future operations in times of crisis. Additionally, our Star Chart analysis reveals that STRYKER CORPORATION is strong in dividend, profitability and medium in growth and weak in asset. All these factors make STRYKER CORPORATION an attractive investment option for investors interested in steady returns. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Stryker Corporation. More…

    Total Revenues Net Income Net Margin
    18.95k 2.63k 14.7%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Stryker Corporation. More…

    Operations Investing Financing
    2.87k -374 -2.22k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Stryker Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    36.83k 19.93k 43.83
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Stryker Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    8.2% 3.5% 17.5%
    FCF Margin ROE ROA
    12.0% 12.5% 5.6%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items




  • Peers

    Stryker Corporation is one of the world’s largest medical technology companies. It offers a broad range of products including orthopedic implants, surgical instruments, medical equipment and software solutions. The company operates in over 100 countries and has a strong presence in the United States, Europe and Asia. Stryker’s competitors include Fukuda Denshi Co Ltd, Nihon Kohden Corp and Shanghai Sanyou Medical Co Ltd.

    – Fukuda Denshi Co Ltd ($TSE:6960)

    Fukuda Denshi Co. Ltd., together with its subsidiaries, manufactures and sells medical electronic equipment in Japan and internationally. The company operates through five segments: Diagnostic Cardiology, Diagnostic Imaging, Patient Monitoring, Electrotherapy, and Others. It offers diagnostic cardiology products, including electrocardiographs, stress test systems, Holter systems, ambulatory blood pressure monitors, and medical printers; and diagnostic imaging products comprising X-ray diagnostic systems, computed tomography systems, magnetic resonance imaging systems, ultrasound diagnostic systems, X-ray angiography systems, and nuclear medicine diagnostic systems. The company also provides patient monitoring products, such as central station systems, telemetry systems, patient monitors, and related accessories; electrotherapy products, such as shortwave diathermy machines and physical therapy equipment; and other products, such as endoscopic and ophthalmologic equipment. It sells its products primarily to general hospitals, clinics, and other health care facilities. The company was founded in 1930 and is headquartered in Tokyo, Japan.

    – Nihon Kohden Corp ($TSE:6849)

    Nihon Kohden Corp. is a Japanese manufacturer of medical equipment, headquartered in Tokyo. The company was founded in 1952 and has since grown to become a leading supplier of medical equipment in Japan. Nihon Kohden’s product lineup includes everything from patient monitors and electrocardiographs to ultrasound machines and medical robotics. The company also offers a wide range of services, including maintenance and repair services for its products.

    Nihon Kohden has a market capitalization of 269.63 billion as of 2022. The company’s return on equity is 11.49%. Nihon Kohden is a leading manufacturer of medical equipment in Japan. The company offers a wide range of products and services, including maintenance and repair services for its products.

    – Shanghai Sanyou Medical Co Ltd ($SHSE:688085)

    Shanghai Sanyou Medical Co Ltd is a medical company with a market cap of 6.32B as of 2022. The company’s return on equity is 8.85%. Shanghai Sanyou Medical Co Ltd is engaged in the research, development, manufacture, and sale of medical devices and equipment. The company’s products include medical imaging equipment, medical consumables, and medical disposables.

    Summary

    Stryker Corporation is a medical technology company that recently saw its stock price underperform the broader market on Wednesday. The stock closed at $290.12, down 0.27% from the previous day. This was a mixed trading session for the overall stock market, as represented by the Dow Jones.

    For investors interested in Stryker Corporation, it is important to keep a close eye on the company’s earnings and market performance, as well as its competitors, in order to make informed decisions on whether to buy, sell, or hold the stock. Analyzing the company’s performance through fundamental and technical analysis, along with news, can also help investors make sound decisions about their investments.

    Recent Posts

    Leave a Comment